Stefani Wolff
Nessuna posizione attualmente
Patrimonio netto: 89 861 $ in data 31/03/2024
Storia della carriera di Stefani Wolff
Precedenti posizioni note di Stefani Wolff
Società | Posizione | Inizio | Fine |
---|---|---|---|
RAIN ONCOLOGY INC. | Director/Board Member | 01/03/2021 | 25/01/2024 |
Independent Dir/Board Member | 01/03/2021 | 25/01/2024 | |
NURIX THERAPEUTICS, INC. | Chief Operating Officer | 14/06/2021 | 02/05/2023 |
PRINCIPIA BIOPHARMA INC. | Corporate Officer/Principal | 01/01/2017 | 28/09/2020 |
BioPharma Consulting Services LLC | Corporate Officer/Principal | 01/05/2016 | 01/01/2017 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 01/05/2013 | 01/12/2015 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Director/Board Member | 01/04/2007 | 01/08/2010 |
ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/09/1989 | 01/04/1997 |
Formazione di Stefani Wolff
The University of North Carolina at Charlotte | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 9 |
Posizioni
Corporate Officer/Principal | 4 |
Director/Board Member | 2 |
Undergraduate Degree | 1 |
Settori
Health Technology | 7 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
NURIX THERAPEUTICS, INC. | Health Technology |
Aziende private | 5 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Principia Biopharma, Inc.
Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Principia Biopharma, Inc. is a biopharmaceutical company, which engages in designing and developing oral therapies to patients with significant unmet medical needs in immunology and oncology. It operates through Tailored Covalency platform, which enables to develop small molecule inhibitors of enzymes and receptor ligands with potencies and selectivities that rival those of injectable biologics, yet maintain the convenience of a pill. Its product pipeline includes PRN1008, PRN2246, PRN1371, and immunoproteasome inhibitor. The company was founded by Jack Taunton and Richard A. Miller on October 6, 2008 and is headquartered in South San Francisco, CA. | Health Technology |
BioPharma Consulting Services LLC | |
Rain Oncology, Inc.
Rain Oncology, Inc. BiotechnologyHealth Technology Rain Oncology, Inc. is a clinical-stage precision oncology company, which focuses on developing and implement the precision oncology therapies for patients suffering from cancer. The company was founded by Avanish Vellanki and Robert Doebele in April 2017 and is headquartered in Newark, CA. | Health Technology |
- Borsa valori
- Insiders
- Stefani Wolff
- Esperienza